Ming-Kai Chen, MD, PhD

Associate Professor of Radiology and Biomedical Imaging; Co-Medical Director, Yale University PET Center

Clinical Interests

  • Hyperthyroidism
  • Medical Oncology
  • Radiology
  • Seizures
  • Thyroid Neoplasms
  • Positron-Emission Tomography

Patient Care

Accepts new patients? Yes
Patient Type: Adult; Adolescent; Child; Geriatric
Referrals: From patients or physicians

Patient Care Organizations

Radiology & Biomedical Imaging: Nuclear Medicine | Positron Emission Tomography (PET)

Yale Medicine

Office of Cooperative Research

Clinical Trials

Conditions Study Title
Leukemia, not otherwise specified A Multicenter, Pivotal Phase 3 Study of Iomab-B Prior to Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia
Mental Health & Behavioral Research Imaging SV2A in mood disorders
Alzheimer's Disease A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease (Generation)
Breast - Female, Breast - Male A Phase I/II Clinical Trial Evaluating the Safety and Clinical Activity of Radioiodide (131I-) as a Novel Targeted Therapy for Metastatic Breast Cancer that Overexpresses Functional Na/I Symporter
Breast - Female A Phase II Randomized, Double-blind, Placebo-controlled Trial of Radium-223 Dichloride Versus Placebo When Administered to Metastatic HER2 Negative Hormone Receptor Positive Breast Cancer Subjects With Bone Metastases Treated With Hormonal Treatment Background Therapy
Lung Low-Dose PET/CT for Imaging Small Lung Nodules
Breast - Female, Breast - Male, Lung, Pancreas, Phase I A Phase II Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors
Diseases of the Nervous System, Mental Health & Behavioral Research SV2A PET Imaging in Healthy Subjects and Epilepsy Patients
Lung Imaging With 11C-erlotinib PET/CT to Identify Responders to Erlotinib Treatment in NSCLC
Alzheimer's Disease 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease (EMERGE)
Addictive Behaviors PET Imaging of mGLuR5 With Drug Challenge
Mental Health & Behavioral Research Translational Neuroscience Optimization of GlyT1 Inhibitor (NCATS)
Mental Health & Behavioral Research PET and MRI Brain Imaging of Bipolar Disorder
Alzheimer's Disease Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. (DIAN-TU)
Addictive Behaviors, Alcohol Addiction, Mental Health & Behavioral Research Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors
Alzheimer's Disease Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss (A4)
Mental Health & Behavioral Research, Tobacco Addiction Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors (nic_physo)
Alzheimer's Disease A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease
Mental Health & Behavioral Research Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 13C-MRS

Edit this profile

Contact Info

Ming-Kai Chen, MD, PhD
Patient Care Location
Nuclear MedicineYale New Haven Hospital
20 York Street, Ste 2nd Floor

New Haven, CT 06510
View on map...
Mailing Address
PO Box 208042
New Haven, CT 06519